Aims: To determine the value of SeHCAT retention in determining bile acid diarrhoea (BAD), treatment response and predictors of a positive result.
Methods: Retrospective casenote review of consecutive patients undergoing SeHCAT from 2008 to 2014, including gender, age, history, clinical, and laboratory parameters. This included diseases associated with Type 1 BAD (ileal resection, Crohn's disease) and Type 3 BAD.